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BACKGROUND: Colorectal cancer (CRC) is one of the
leading causes of cancer-related deaths in the United
States. Randomized controlled trials have shown that
annual screening fecal occult blood testing (FOBT)
reduces CRC mortality and incidence. However, patient
compliance with FOBT is low.
OBJECTIVE: To determine whether a mailed educational
reminder increases FOBT card return rates and to
examine predictors of FOBTcompliance.
DESIGN: Blinded, randomized, controlled trial at the
Veteran Affairs Medical Center, San Diego, California.
PATIENTS: Seven hundred and seventy-five consecutive
patients ≥50 years of age referred by their primary care
physicians for FOBT.
INTERVENTION: Patients were randomly assigned to
the usual care group or the intervention group. Ten
days after picking up the FOBT cards, a 1-page
reminder with information related to CRC screening
was mailed to the intervention group only.
MEASUREMENTS: The primary outcome was propor-
tion of returned FOBT cards after 6 months. Patient
demographic, clinical characteristics and prior FOBT
completed were collected for multivariate regression
analysis.
RESULTS: At 6 months after card distribution, 64.6%
of patients in the intervention group returned cards
compared with 48.4% in the control group (P<0.001).
Patients who received a mailed reminder (OR 2.02; 95%
CI: 1.48–2.74) or have a prior history of returning the
FOBT cards (OR 1.87; 95% CI: 1.29–2.70) were more
likely to return the FOBTcards. Patients with current or
recent illicit drug use were less likely to return the
FOBT cards (OR 0.26; 95% CI: 0.13–0.50).
CONCLUSION: A simple mailed educational reminder
significantly increases compliance with FOBT for CRC
screening.
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INTRODUCTION
Colorectal cancer (CRC) is one of the leading causes of cancer-
related deaths in the United States and a common cause of
morbidity and mortality worldwide
1. In 2008, about 148,000
new cases of CRC will be diagnosed, and about 50,000 people
will die from this disease
2. Several randomized controlled trials
have shown evidence for the effectiveness of fecal occult blood
testing (FOBT) in reducing CRC mortality by using samples
from three successive stools
3,4.
National efforts have been made to increase awareness of
CRC screening over the past several years. Recently, the
United States Preventive Services Task Force (USPSTF) and
National Comprehensive Cancer Network (NCCN) recommended
all individuals within age 50 to 75 years, who are at average
risk for CRC, to use one of the following methods for CRC
screening: an annual high sensitivity FOBT, a flexible sigmoid-
oscopy every 5 years, or a colonoscopy every 10 years
5,6.A
Veteran Affairs (VA) directive based on previous US Multi
Society Task Force and USPSTF guidelines
7,8 recommended
screening of all eligible patients using any one of five methods,
including annual FOBT testing, flexible sigmoidoscopy every
five years, the combination of annual FOBT and every five year
flexible sigmoidoscopy, double contrast barium enema every
5 years, or colonoscopy alone every 10 years. Despite these
recommendations and guidelines, CRC screening rates remain
low. As of 2006, almost 40% of adults age 50 years or older were
not up-to-date with CRC screening
2.N u m e r o u ss t u d i e sh a v e
shown that patient compliance in CRC screening programs and
FOBT card return rates are suboptimal
9–12. As a result, interest
in new effective and inexpensive interventions remains high.
One method of improving compliance with screening guide-
lines is a patient-oriented reminder. Several studies have
shown that mailed reminders can be effective, efficient, and
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1192inexpensive in improving cervical and breast cancer screening
rates
13–15. However, few studies have evaluated whether any
type of patient reminder can improve FOBT card return rates
for CRC screening
9. We conducted a double-blind, randomized
controlled trialtoexamine whether a mailed educational reminder
would increase FOBT card return rates. Our secondary objective
was to identify demographic and clinical characteristics associ-
ated with FOBTcompliance.
METHODS
Design Overview
To test the effect of a mailed educational reminder on
increasing FOBT card return rate for CRC screening, we
conducted a double-blind, randomized controlled trial in a
U.S. veteran patient population. Figure 1 shows a flow diagram
of our study design. Patients meeting inclusion criteria were
randomly assigned to receive either usual care or usual care
with a mailed educational reminder (intervention). The clinical
research associate mailed all educational reminders 10 days
after the patients received their FOBT cards. Patients were
given 6 months to return the FOBT cards. The Institutional
Review Board (IRB) of the University of California, San Diego
(UCSD) and the Research and Development Committee of the
VA San Diego Healthcare System approved the study.
Study Setting and Population
We evaluated patients from the VA Medical Center primary
care clinics in San Diego and Vista between June 1 and
September 9, 2007. The study included asymptomatic men
and women age 50 years or older who agreed to screening and
received FOBT card kits with a postage paid return envelope.
Under usual care, primary care physicians (PCP) entered a
computerized order for FOBT testing, and then patients were
instructed by the PCP to pick up FOBT cards for CRC
screening from the laboratory and return them for analysis.
Patients were excluded from this study if they were less than
50 years of age, were currently on an inpatient unit, or refused
to undergo any routine CRC screening. CRC screening was
performed in primary care clinics in accordance with VHA
Directive 2007–004 CRC Screening (www1.va.gov/cancer/
docs/VHA_Colorectal_Cancer_Screening_2007–004.DOC),
based on recommendations from the US Multi Society Task
Force (2003) and the US Preventive Services Task Force
(2002)
7,8. The decision regarding which screening test to
choose is dependent on patient and physician choice and local
resource availability. We did not exclude any patients over the
age of 75 as recommended by the USPSTF in 2008, because
our study was performed prior to the 2008 guidelines
5.
Randomization and Intervention
Using a random-number generator, the clinical research
associate randomly and sequentially assigned patients who
met inclusion criteria, without blocking or stratification, to
usual care (control) group versus an intervention group
(mailed educational reminder). The randomization process
and group assignment occurred after the chart review, ensur-
ing that members of the study team abstracting data from the
medical charts were blinded to the randomization results and
the FOBT card return status.
The mailed educational reminder consisted of an 8.5×11 inch
paper folded in thirds, personalized, sealed, and sent to the
subjects’ home address 10 days after the patients were given
their FOBT cards by the clinical laboratory (Online appendix) .
The content of the letter incorporated both a reminder and
educational element based on a similar study using a mailed
educational reminder for colonoscopy screening
16.T h e
mailed letter was one-sided, written at an eighth-grade reading
level
17, and contained a reminder to return their FOBT cards
on the top portion of the letter. The middle portion of the letter
Figure 1. Flow Diagram through the study. CRC: Colorectal Cancer.
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who is affected by the disease, and the benefits of getting
screened. On the bottom third of the letter was a quote from a
United States Veteran colon cancer survivor, who emphasized
the importance of colorectal cancer screening. Lastly, the
reminder contained a direct 24-hour, 7-day a week, VA
laboratory phone number for any questions about the FOBT.
The IRB at our institution granted exemption of informed
consent because of the minimal risk associated with the
mailed reminder and a guarantee of at least usual care for all
patients.
Study Outcomes
The primary outcome of this study was the proportion of
patients who returned the FOBT cards within 6 months. Our
outcome measure was based on chart review by a clinical
research assistant who was blinded to the patients’ trial arm
assignments. If a mailed educational reminder was returned
by the post office as undeliverable, no further mailings were
sent; however, the patient was retained in the sample for an
intention-to-treat analysis.
Our secondary outcome was to identify factors associated
with successfully returning FOBT cards. Using administrative
databases and the VA’s electronic medical record database, we
retrospectively collected information on all patients who
received FOBT cards and were enrolled in our study. Study
members who performed the chart review were blinded to both
trial assignment and FOBT card return status. A systematic
method of data abstraction was used to collect the following
information for each patient: age, gender, marital status, race/
ethnicity, median household income by postal code of resi-
dence, number of other scheduled and kept VA appointments
for the 1-year period prior to obtaining FOBT cards, prior
number of FOBT cards returned in the past, current warfarin
use, history of hepatitis C or HIV, family or personal history of
CRC, history of anxiety, mood, or psychotic disorders, current
or recent use of illicit drugs, and current use of tobacco or
alcohol. Patients were given a diagnosis of mood, anxiety, or
psychotic disorder if they were currently taking psychiatric
medications, were given a corresponding ICD-9 code, or were
previously diagnosed by their psychiatrist, primary care
physician, or psychologist. Current or recent use of illicit
drugs (marijuana, cocaine, amphetamines, opiates, and hero-
in) was defined as any documented record of illicit drug use or
positive urine toxicology 6 months before or after picking up
their FOBT cards from the laboratory.
Statistical Analysis
In determining our sample size, we hypothesized that patients
in the intervention group would have at least 10% greater
FOBT card return rate than patients in the usual care group.
We estimated that compliance in the control group would be
about 50%, based on a 51.3% rate described in a similar study
of a similar population
11. To test our hypothesis, the target
sample size was 792 patients (or 396 in each group) using a
two-sided chi-square test with 80% power and alpha value set
at 0.05.
Subjects in the control group were compared with subjects
in the intervention group. Comparisons for continuous vari-
ables and categorical variables were made using the Student
t test and chi square analysis, respectively. The Wilcoxon rank
sum test was used when the normal distribution assumption
was not met for a continuous variable.
We used univariate and multivariate logistic regression
analysis to determine predictors of compliance with FOBT.
Univariate predictors with a P value less than 0.05 were
entered into a multivariate forward logistic regression model
to generate adjusted odds ratios (OR) with 95% confidence
intervals (CI). Each independent variable retained in the
multiple logistic regression model had a significance level of
P<0.05. All statistical analyses were performed using SPSS
software version 16.0 for Macintosh (SPSS, Chicago, IL).
RESULTS
Study Participants
Among 846 patients who received FOBT cards for CRC
screening during our 3-month enrollment period, 775 were
determined eligible and were randomized to receive either a
mailed educational reminder or usual care (Fig. 1). Seventy-
one patients were excluded either due to their age (59 patients
were less than 50 years old) or duplicate referral (12 patients).
Six patients died within 6 months after receiving their FOBT
cards and were excluded from the final analysis. Thus, our
final sample size for analysis was 769 patients. The baseline
demographic and clinical characteristics were well matched in
both the control and intervention groups (Table 1). The mean
age of our study participants was 63.1 years (SD=9.6). The
majority of our study participants were male (96.3%), Caucasian
(72.8%), and not married (56.6%); the largest minority group in
the cohort was African-Americans(11.7%). Manymembers of the
cohort were currently drinking alcohol (45.0%) and smoking
tobacco (27.6%), but only a few were noted to be currently or
recently using illicit drugs (6.5%). Major psychiatric disorders
present in our cohort were anxiety disorders (11.3%) and mood
disorders (28.9%).
Primary Outcome
Overall, 435 of the 769 participants (56.6%) returned the
FOBT cards within 6 months. The proportion of patients who
returned the FOBT cards was significantly higher in the mailed
reminder group than those who did not receive a reminder
(64.6% vs. 48.4%; P<0.001). At 6 months after card distribu-
tion, the FOBT card return rate was 16.2 percentage points
greater in the intervention group than in the control group
(Fig. 2). This represents a 33.5% increase in the FOBT card
return rate. As shown in Figure 2, more than 90% of our
participants returned their FOBT cards within 60 days of
receiving the test from the laboratory.
Multivariate Analysis
Demographics, clinical characteristics, percentage of other VA
appointments kept, and number of prior FOBT completed in
the past were compared among patients who were compliant
and non-compliant with FOBT as shown in Table 2. Patients
who received a mailed reminder, older age group (≥70 years
versus 50–59 years), percentage of other VA appointments
kept, prior FOBT completed in the past, history of mood
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statistically significant in univariate analysis. Multivariate
logistic regression analysis (Table 3) showed that receiving a
mailed reminder (OR 2.02; 95% CI: 1.48–2.74) and prior
history of FOBT completion (OR 1.87; 95% CI: 1.29–2.70) were
significant predictors of compliance with FOBT. Current or
recent use of illicit drugs (OR 0.26; 95% CI: 0.13–0.50) was a
significant predictor of non-compliance. The data presented in
Table 3 also show that the odds of compliance increases with
each number of prior FOBT completed. Compliance rates were
significantly higher for those who completed one (OR 1.87), two
(OR 3.89), or three or more (OR 4.05) FOBT kits in the past
compared with patients who had never returned a FOBT kit.
Table 1. Baseline Demographics and Clinical Characteristics
Characteristics Usual care
(n=382)
Intervention
group (n=387)
Mean age, years(SD) 63.1(9.6) 62.9(9.6)
Men, n (%) 367(96.1) 374(96.6)
Race / Ethnicity, n (%)
White 277(72.5) 283(73.1)
Black 40(10.5) 50(12.9)
Hispanic 31(8.1) 27(7.0)
Other 34(9.9) 27(7.0)
Marital status, n (%)
Not married 221(57.9) 214(55.3)
Married 161(42.1) 173(44.7)
Family history of CRC, n (%) 14(3.7) 21(5.4)
Personal history of CRC, n (%) 10(2.6) 13(3.4)
No. of prior FOBT, n (%)
None 202(52.9) 182(47.0)
1 81(21.2) 106(27.4)
2 43(11.3) 47(12.1)
3+ 56(14.7) 52(13.4)
Median income by postal code of
residence
≤$29,999 32(9.1) 46(12.8)
$30,000 – $39,999 61(17.4) 50(14.0)
$40,000 – $49,999 115(32.9) 111(31.0)
$50,000 – $59,999 43(12.3) 64(17.9)
$60,000 – $69,999 63(18.0) 53(14.8)
≥$70,000 36(10.3) 34(9.5)
Mean percentage of other VA
appointments kept, mean (SD)
90.8(13.7) 91.9(26.8)
Psychiatric disease, n (%)
Anxiety disorder 42(11.0) 45(11.6)
Mood disorder 98(25.7) 124(32.0)
Psychotic disorder 11(2.9) 11(2.8)
Current illicit drug use, n (%) 24(6.3) 26(6.7)
Current alcohol use, n (%) 177(46.3) 169(43.7)
Current tobacco use, n (%) 95(24.9) 117(30.2)
Hepatitis C 31(8.1) 33(8.5)
HIV 12(3.1) 10(2.6)
Current warfarin use, n (%) 28(7.3) 22(5.7)
CRC: colorectal cancer
VA: Veteran Affairs
HIV: human immunodeficiency virus
Figure 2. Cumulative adherence over time by study. FOBT: Fecal
Occult Blood Test.
Table 2. Univariate Analysis of Predictors of FOBT Compliance
Univariate
odds ratio
95%
confidence
interval
Received mailed reminder 1.94 1.45–2.60
Age group
60–69 versus 50–59 1.38 0.99–1.91
≥70 versus 50–59 1.81 1.25–2.63
% of VA appt. kept (per %) 1.01 1.00–1.02
Male gender 0.72 0.33–1.57
Race group
Black versus white 1.08 0.69–1.70
Hispanic versus white 0.66 0.38–1.13
Other versus white 1.09 0.64–1.86
Married 1.19 0.89–1.59
Family history of CRC 1.32 0.65–2.65
Personal history of CRC 1.78 0.73–4.40
Prior FOBT returned group
1 versus 0 1.95 1.36–2.78
2 versus 0 3.85 2.29–6.48
≥3 versus 0 3.93 2.42–6.38
Median household income by postal code
$30,000–39,999 vs. ≤$29,999 1.20 0.67–2.15
$40,000–49,999 vs. ≤ $29,999 1.16 0.69–1.93
$50,000–59,999 vs. ≤ $29,999 1.59 0.88–2.88
$60,000–69,999 vs. ≤ $29,999 1.61 0.90–2.89
≥$70,000 vs. ≤ $29,999 1.13 0.59–2.15
Anxiety disorder 1.29 0.82–2.05
Mood disorder 0.72 0.53–0.99
Psychotic disorder 0.63 0.27–1.48
Current or recent illicit drug use 0.28 0.15–0.52
Current alcohol use 0.96 0.72–1.28
Current tobacco use 0.64 0.47–0.88
Hepatitis C 0.80 0.48–1.34
HIV 0.76 0.33–1.78
Current warfarin use 1.16 0.65–2.09
CRC: colorectal cancer
VA: Veteran Affairs
HIV: human immunodeficiency virus
Table 3. Multiple Logistic Regression Model of Predictors of FOBT
Compliance
Adjusted
odds ratio
95% confidence
interval
Received a mailed reminder 2.02 1.48–2.74
Prior FOBT returned group
1 versus 0 1.87 1.29–2.70
2 versus 0 3.89 2.29–6.63
≥3 versus 0 4.05 2.46–6.66
Current or recent illicit drug use 0.26 0.13–0.50
Age group
60–69 versus 50–59 1.08 0.76–1.54
≥70 versus 50–59 1.18 0.78–1.78
% of VA appt. kept (per %) 1.03 0.99–1.01
Mood disorder 0.78 0.56–1.09
Current tobacco use 0.80 0.57–1.14
FOBT: fecal occult blood test
1195 Lee et al.: Improving Colorectal Cancer Screening Compliance JGIMPatients who received a mailed reminder were 2.02 times more
likely to return the FOBT than those patients who did not
receive a mailed reminder. Patients who were currently or
recently using illicit drugs were 74% less likely to return the
FOBT kits compared to non-illicit drug users. We repeated our
analysis removing the intervention as a covariate in the
multivariable model and none of the results were significantly
altered. No patient characteristics were found to modify the
effect of the mailed reminder on FOBT card return rate.
DISCUSSION
Our blinded, randomized, controlled study showed that a
simple, low cost mailed educational reminder resulted in an
absolute 16.2 percentage point higher FOBT card return rate
compared with usual care (64.4% vs. 48.4%) in patients that
had received face-to-face discussions with their PCP
concerning CRC screening and who agreed to this type of
screening.
Our study was not designed to determine overall compliance
with FOBT testing, but some estimates of this can be made.
During the study period, FOBT testing was ordered by PCPs in
1569 patients. Overall, 846 patients complied and received
FOBT cards, which represents an overall 53.9% compliance
rate (Fig. 1). Of the 769 eligible participants, 435 (56.6%)
returned the FOBT cards, and the absolute return rate was
64.4% in patients receiving a mailed reminder and 48.4% in
usual care patients. Extrapolating this to the overall rate of
successful FOBT compliance in the total group for which FOBT
testing was ordered, the use of a mailed reminder may increase
overall FOBT compliance from 409/1569 (26.1%) to 545/1569
(34.7%), which again represents a relative increase of 33%.
Again, this presumes that FOBT testing was ordered for the
purpose of CRC screening in all 1569 patients, but data are
not available to verify this in all patients who did not comply
with FOBT and not included in the study.
A prior review of participation in CRC screening documented
overall FOBT compliance rates ranging from 10% to 50%,
depending on the study population, setting, and type of inter-
vention
9. In three randomized trials, the compliance rates of
selected patients that agreed to undergo FOBT testing were
59.6% to 75.2%
3,4,18. In contrast, compliance was much lower in
community based mass screening programs, ranging from 26%
to 48%
11,12,19,20.
Various patient interventions have been studied to increase
FOBT compliance including telephone reminders, postal
reminders, letters signed by personal physicians, and other
educational strategies
9. However, despite the most intensive
strategies delivered to well-defined populations of eligible
patients, overall FOBT adherence rarely increased above 50%
9.
More recently, Stokamer et al. conducted a randomized, con-
trolled trial to examine whether intense patient education from
nurses would increase FOBT card return rates in U.S. Veteran
patients
11. The investigators were able toshow that a one-on-one
10–15 minute educational session regarding the importance of
CRC screening and FOBT by nurses increased FOBTcompletion
rates to 65.9% compared with 50.1% in the control group.
Despite the significant increase in FOBT completion rates,
implementing this intervention would likely be expensive and
time-consuming.
Prior studies of mailed reminders for improving CRC
screening rates have shown mixed results, with minimal
improvement documented in unselected patients
21,22. More
recently, although not related to FOBT adherence, Denberg et
al. were able to show that a 1 page 2-sided mailed reminder
significantly increased colonoscopy appointment adherence by
11.7% and was cost-effective
16,23. The study participants in
Denberg’s randomized controlled study were non-volunteers
and were blinded to their involvement.
Limited data have been published describing patient-related
factors that are associated with compliance and non-compli-
ance with FOBT based screening. Using our diverse and large
cohort, we identified several independent predictors of FOBT
compliance, which include having received a mailed reminder
and prior history of FOBT completion. The only negative
significant factor associated with FOBT compliance was cur-
rent or recent illicit drug use.
In our pooled sample, patients who had completed one, two,
or three or more FOBT kits in the past were more likely to
return the FOBT than those who had never completed an
FOBT kit. Our observation of prior FOBT completed as a
positive predictor of FOBT completion is not surprising.
Patients who have completed the test in the past are more
likely to be unaffected by the process of collecting their own
stool samples, which has been shown to be one of the major
barriers to FOBT compliance
24. We also found that patients
who were currently or recently using illicit drugs were 74% less
likely to return the FOBT cards than non-illicit drug users.
This observation again is not surprising because patients who
continue to participate in risky behaviors such as illicit
drug use may lack interest in their own healthcare. To our
knowledge, this is the first study to show current or recent
illicit drug use as a significant negative predictor of CRC
screening. It is likely that illicit drug use is much more
prevalent than our study reports due to the lack of systematic
reporting and questioning from physicians and the refutation
by patients. These data indicate that providers should take
steps in addressing their patients’ current or recent illicit drug
use, while at the same time take extra steps to encourage CRC
screening.
The strengths of our study include: the simplicity and low
cost of the intervention; the large sample size; blinded,
randomized control design; low exclusion criteria; long-term
follow up allowing adequate time for participants to return the
FOBT cards; and a comprehensive computerized medical
record system to identify predictors of compliance. This study
also has several limitations. First, we only enrolled patients
who picked up their FOBT cards at the laboratory after their
PCP visit, and do not report the overall compliance with FOBT
testing ordered by PCPs. However, we have made some
estimates of overall compliance as indicated above. Second,
our sample was comprised of U.S. Veteran patients from San
Diego, California, which limits the generalizability of our
findings. For example, financial barriers for VA patients may
be less than a population with lower levels of health insurance.
Third, our study was unable to determine the relative degree to
which compliance was influenced by the reminder itself, the
patient quote regarding CRC screening, or the educational
facts regarding CRC. Fourth, we did not exclude any patients
over the age of 75 as recommended by the USPSTF in 2008
5,
because our study was performed prior to these recommenda-
tions. Lastly, current guidelines call for the use of more
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potentially DNA testing; however these methods of screening
have not yet been widely adopted. The results of this study would
be highly relevant for these tests and would help enhance the
cost-effectiveness of this approach to CRC screening.
In summary, a simple, inexpensive mailed educational
reminder significantly improved FOBT card return rates for
CRC screening. A factor associated with FOBT noncompliance
is current or recent illicit drug use; and steps to address these
issues are warranted. The results of this study also indicate
that further improvements in patient compliance with CRC
screening are needed. Whether adding another reminder
would increase patient compliance further is an important
topic for future investigation. Further studies are also recom-
mended to assess the impact of other educational or motiva-
tional techniques, such as e-mail reminder, cell phone text
messaging reminders, or specific incentives for compliance
with cancer screening tests.
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